Neurosurgery News and Research RSS Feed - Neurosurgery News and Research

Butler neuropsychologist studies OCD patients undergoing gamma knife radiosurgery

Butler neuropsychologist studies OCD patients undergoing gamma knife radiosurgery

Supported by a $750,000 K23 Career Development Award from the National Institutes of Health, Butler Hospital neuropsychologist Nicole McLaughlin, PhD, is conducting a first-of-its-kind study of patients with obsessive-compulsive disorder (OCD) undergoing gamma knife radiosurgery. [More]
Study finds lower mortality at hospitals that treat high volume of SAH cases

Study finds lower mortality at hospitals that treat high volume of SAH cases

For patients with a severe type of stroke called subarachnoid hemorrhage (SAH), treatment at a hospital that treats a high volume of SAH cases is associated with a lower risk of death, reports a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
UH's Neurological Institute designated as Gold Center of Excellence

UH's Neurological Institute designated as Gold Center of Excellence

The Neurological Institute at University Hospitals has been designated as a Gold Center of Excellence (COE) and featured as a top performing center by NeuStrategy, Inc., a Chicago consulting firm providing strategic support to neuroscience, oncology and orthopaedic service providers. [More]

Codman Neuro releases SPETZLER MALIS Dual Irrigating Forceps for neurosurgery

Codman Neuro, a global leader in neurosurgery and part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of SPETZLERTM MALIS Dual Irrigating Disposable Non-Stick Bipolar Forceps, the first disposable dual irrigating forceps for neurosurgery. [More]
NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery. [More]
Cell transplantation treatment may benefit people with spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies. [More]
Caregivers more aware of SUDEP than patients

Caregivers more aware of SUDEP than patients

Sudden unexpected death in epilepsy (SUDEP) is concerning and many—even those with seizure disorders—may not be aware of this condition. New research published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), reports that 76% of caregivers are more likely to have heard of SUDEP compared with 65% of patients with epilepsy. [More]
NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

The New York Stem Cell Foundation today named six of the most promising scientists as its 2014 NYSCF – Robertson Investigators. [More]
Leica Microsystems launches new neurosurgical microscope

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue. [More]
Research finding offers new insights into the cause of glioblastoma

Research finding offers new insights into the cause of glioblastoma

Researchers at the University of California, San Diego School of Medicine have identified a new fusion protein found in approximately 15 percent of secondary glioblastomas or brain tumors. The finding offers new insights into the cause of this cancer and provides a therapeutic target for personalized oncologic care. [More]
Longer looks: Limits on doctor training; a woman's campaign for end-of-life choices

Longer looks: Limits on doctor training; a woman's campaign for end-of-life choices

Dr. Dino Terzic got lucky the other day. In his seventh and final year as a neurosurgery resident at the University of Minnesota, the 32-year-old Bosnian got to operate on a rare type of brain aneurysm that required a special approach through the patient's forehead. As Terzic prepared to slice into the patient's scalp, he was asked if he'd ever seen this type of flaw in an artery, which occurs in just 2 to 3 percent of aneurysm cases. "On a video," Terzic replied with a chuckle. Terzic's hands-on experience shows why the nation's medical schools are beset by a nagging controversy over rules that limit the number of hours residents can work (Dan Browning, 10/8). [More]
InSightec to share new insights at FUS symposium

InSightec to share new insights at FUS symposium

InSightec, world leader in MR-guided Focused Ultrasound (MRgFUS) will be on site at the Focused Ultrasound International Symposium (FUS) to share key insights gained in the past two years of using its non-invasive MRgFUS solution for treating a variety of neurosurgical, oncological and gynecological indications. [More]
USC researchers develop new methods to advance study of human brains, epilepsy

USC researchers develop new methods to advance study of human brains, epilepsy

USC biomedical engineers, neurologists and neurosurgeons develop new methods to advance the study of human brains and epilepsy. Studying the human brain is logistically complicated. Living samples of the complex and sensitive organ are limited and difficult to preserve, which means that research on them must be conducted quickly before they expire. [More]
U-M scientists launch $11.5 million effort to better understand cause of Parkinson's disease

U-M scientists launch $11.5 million effort to better understand cause of Parkinson's disease

Deep in the brains of the million Americans with Parkinson's disease, changes to their brain cells put them at high risk of dangerous falls -- a problem that resists even the most modern treatments. [More]
Brain cancer patients can benefit from Rapamycin drug

Brain cancer patients can benefit from Rapamycin drug

Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts. [More]
Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

A multidisciplinary team of experts affiliated with the Cedars-Sinai Movement Disorders Program will present a free conference for patients, families and caregivers on treatment options for dystonia, which causes painful and potentially crippling muscle contractions. [More]
CFDA clears Elekta's Versa HD radiation therapy system

CFDA clears Elekta's Versa HD radiation therapy system

Following US and European approvals of Elekta's Versa HD™ linear accelerator, the China Food and Drug Administration (CFDA) has cleared the radiation therapy system for sale and marketing in the country. [More]
Lya Segall Ovarian Cancer Institute at Mercy opens in Maryland

Lya Segall Ovarian Cancer Institute at Mercy opens in Maryland

Mercy Medical Center has announced the opening of The Lya Segall Ovarian Cancer Institute at Mercy, the first center in Maryland specifically designed and dedicated solely for the diagnosis and treatment of ovarian cancer. [More]
Researchers explore gene expression in normal vestibular nerves, vestibular schwannomas

Researchers explore gene expression in normal vestibular nerves, vestibular schwannomas

Researchers from the University of Toronto, directed by Drs. Gelareh Zadeh and Boris Krischek, investigated gene expression in normal vestibular nerves and vestibular schwannomas (VSs). [More]
Misonix provides ultrasonic BoneScalpel to support Uganda Spine Surgery Mission

Misonix provides ultrasonic BoneScalpel to support Uganda Spine Surgery Mission

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announces that it has once again supported the Uganda Spine Surgery Mission organized by leading spine surgeon Dr. Isador Lieberman, from the Texas Back Institute in Plano, TX, by providing an ultrasonic BoneScalpel for use in a number of advanced spinal surgeries. [More]